https://doi.org/10.4081/reumatismo.2016.873
New approved drugs for psoriatic arthritis
Submitted: 22 February 2016
Accepted: 13 July 2016
Published: 9 September 2016
Accepted: 13 July 2016
Abstract Views: 2864
PDF: 2130
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Perrotta, F., & Lubrano, E. (2016). New approved drugs for psoriatic arthritis. Reumatismo, 68(2), 57–64. https://doi.org/10.4081/reumatismo.2016.873
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- A. Trotta, A. Corrado, F.P. Cantatore, Anabolic therapy in b-thalassaemia major induced osteoporosis: case report and literature review , Reumatismo: Vol. 62 No. 2 (2010)
- P. Piscitelli, M.L. Brandi, U. Tarantino, A. Baggiani, A. Distante, M. Muratore, V. Grattagliano, A. Migliore, M. Granata, G. Guglielmi, R. Gimigliano, G. Iolascon, Incidence and socioeconomic burden of hip fractures in Italy: extension study 2003-2005 , Reumatismo: Vol. 62 No. 2 (2010)
- F. Ursini, TNF-alpha and insulin-resistance: metabolic effects of in vivo therapeutic blockade , Reumatismo: Vol. 61 No. 4 (2009)
- G. Fornaciari, V. Giuffra, Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici , Reumatismo: Vol. 61 No. 3 (2009)
- N. Bizzaro, M. Tampoia, Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides , Reumatismo: Vol. 61 No. 3 (2009)
- M. Gutierrez, E. Filippucci, F. Salaffi, W. Grassi, The current role of ultrasound in the assessment of crystal-related arthropathies , Reumatismo: Vol. 61 No. 3 (2009)
- F. Cozzi, P. Marson, Plasma-exchange in the treatment of systemic rheumatic diseases: past and present experience , Reumatismo: Vol. 61 No. 3 (2009)
- K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar, Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis , Reumatismo: Vol. 61 No. 1 (2009)
- F. Atzeni, P. Sarzi-Puttini, Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients? , Reumatismo: Vol. 61 No. 1 (2009)
- M.G. Portuesi, M. Lancia, L. Ciuffreda, Problem of differential diagnosis between Crohn’s disease and colitis in Behçet’s disease: a case report , Reumatismo: Vol. 62 No. 2 (2010)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
You may also start an advanced similarity search for this article.
